Fazarabine: a report of response in a patient with multiply relapsed embryonal cell carcinoma.

  • 1 February 1993
    • journal article
    • case report
    • Vol. 16  (1) , 34-7
Abstract
This report describes a patient with multiply relapsed and advanced metastatic embryonal cell carcinoma who achieved a pathological partial remission (PR) following treatment with a Phase I chemotherapeutic agent, arabinosyl-5-azacytosine (Ara-AC), followed by orchiectomy. The antimetabolic Ara-AC is worthy of further study in patients with germ-cell tumors. It would appear that the antimetabolite Ara-AC may have significant activity in patients with germ-cell tumors.

This publication has 0 references indexed in Scilit: